Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/105815
DC FieldValueLanguage
dc.contributor.authorAlves, Celso H.-
dc.contributor.authorSerrano, Eurico-
dc.contributor.authorSilva, Joana-
dc.contributor.authorRodrigues, Carlos-
dc.contributor.authorPinteus, Susete-
dc.contributor.authorGaspar, Helena-
dc.contributor.authorBotana, Luis M.-
dc.contributor.authorAlpoim, Maria C.-
dc.contributor.authorPedrosa, Rui-
dc.date.accessioned2023-03-09T10:20:09Z-
dc.date.available2023-03-09T10:20:09Z-
dc.date.issued2020-08-
dc.identifier.issn07533322pt
dc.identifier.urihttps://hdl.handle.net/10316/105815-
dc.description.abstractCancer is one of the major threats to human health and, due to distinct factors, it is expected that its incidence will increase in the next decades leading to an urgent need of new anticancer drugs development. Ongoing experimental and clinical observations propose that cancer cells with stem-like properties (CSCs) are involved on the development of lung cancer chemoresistance. As tumour growth and metastasis can be controlled by tumour-associated stromal cells, the main goal of this study was to access the antitumor potential of five bromoterpenes isolated from Sphaerococcus coronopifolius red alga to target CSCs originated in a co-culture system of fibroblast and lung malignant cells. Cytotoxicity of compounds (10-500 μM; 72 h) was evaluated on monocultures of several malignant and non-malignant cells lines (HBF, BEAS-2B, RenG2, SC-DRenG2) and the effects estimated by MTT assay. Co-cultures of non-malignant human bronchial fibroblasts (HBF) and malignant human bronchial epithelial cells (RenG2) were implemented and the compounds ability to selectively kill CSCs was evaluated by sphere forming assay. The interleucine-6 (IL-6) levels were also determined as cytokine is crucial for CSCs. Regarding the monocultures results bromosphaerol selectively eliminated the malignant cells. Both 12S-hydroxy-bromosphaerol and 12R-hydroxy-bromosphaerol steroisomers were cytotoxic towards non-malignant bronchial BEAS-2B cell line, IC50 of 4.29 and 4.30 μM respectively. However, none of the steroisomers induced damage in the HBFs. As to the co-cultures, 12R-hydroxy-bromosphaerol revealed the highest cytotoxicity and ability to abrogate the malignant stem cells; however its effects were IL-6 independent. The results presented here are the first evidence of the potential of these bromoterpenes to abrogate CSCs opening new research opportunities. The 12R-hydroxy-bromosphaerol revealed to be the most promising compound to be test in more complex living models.pt
dc.language.isoengpt
dc.publisherElsevierpt
dc.relationUID/MAR/04292/ 2020pt
dc.relationUID/Multi/04046/2020pt
dc.relationPTDC/ MAR-BIO/6149/2014pt
dc.relationPOCI-01-0145- FEDER-016791pt
dc.relationOncologia de Precisão: Terapias e Tecnologias Inovadoras project (POINT4PAC) (SAICTPAC/0019/2015 - LISBOA-01-0145-FEDER-016405)pt
dc.relationCROSS-ATLANTIC project (PTDC/BIA-OUT/29250/2017), co-financed by COMPETE (POCI- 01-0145-FEDER-029250)pt
dc.relationIntegrated Programme of SR&TD "Smart Valorization of Endogenous Marine Biological Resources Under a Changing Climate" (reference Centro-01- 0145-FEDER-000018)pt
dc.relationSFRH/ BD/103255/2014pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt
dc.subjectMarine natural productspt
dc.subjectRed seaweedpt
dc.subjectLung cancerpt
dc.subjectCancer stem cellspt
dc.subjectMicroenvironmentpt
dc.subjectInterleukin-6pt
dc.subject.meshAntineoplastic Agents, Phytogenicpt
dc.subject.meshCell Line, Tumorpt
dc.subject.meshCell Survivalpt
dc.subject.meshCoculture Techniquespt
dc.subject.meshDose-Response Relationship, Drugpt
dc.subject.meshHumanspt
dc.subject.meshInhibitory Concentration 50pt
dc.subject.meshInterleukin-6pt
dc.subject.meshLung Neoplasmspt
dc.subject.meshNeoplastic Stem Cellspt
dc.subject.meshTerpenespt
dc.subject.meshTumor Microenvironmentpt
dc.subject.meshRhodophytapt
dc.titleSphaerococcus coronopifolius bromoterpenes as potential cancer stem cell-targeting agentspt
dc.typearticle-
degois.publication.firstPage110275pt
degois.publication.titleBiomedicine and Pharmacotherapypt
dc.peerreviewedyespt
dc.identifier.doi10.1016/j.biopha.2020.110275pt
degois.publication.volume128pt
dc.date.embargo2020-08-01*
uc.date.periodoEmbargo0pt
item.cerifentitytypePublications-
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
crisitem.author.orcid0000-0001-9776-5701-
crisitem.author.orcid0000-0003-1685-9883-
crisitem.author.orcid0000-0002-1613-7023-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
1-s2.0-S0753332220304674-main.pdf2.58 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

10
checked on May 20, 2024

WEB OF SCIENCETM
Citations

10
checked on May 2, 2024

Page view(s)

52
checked on May 14, 2024

Download(s)

33
checked on May 14, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons